Fluad Tetra (influenza vaccine (surface antigen, inactivated, adjuvanted))
- Region
- 🇪🇺 EU
- Active substance
- influenza vaccine (surface antigen, inactivated, adjuvanted)
- Company
- Seqirus Netherlands B.V.
- Status
- Withdrawn
- Therapeutic area
- Influenza, Human
- CHMP opinion
- Thu 26 Mar 2020
- EU approval
- Wed 20 May 2020
- Application
- EMEA/H/C/004993
- ATC
- J07BB02
- Official record
- www.ema.europa.eu
Indication
Prophylaxis of influenza in adults 50 years of age and older. Fluad Tetra should be used in accordance with official recommendations.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Aujemflu Authorised · Seqirus Netherlands B.V.
- 🇪🇺 Fluad Authorised · Seqirus Netherlands B.V.
- 🇪🇺 Flucelvax Authorised · Seqirus Netherlands B.V.
- 🇪🇺 Flucelvax Tetra Withdrawn · Seqirus Netherlands B.V.
- 🇪🇺 Optaflu Expired · Seqirus GmbH
Follow Fluad Tetra
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.